Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)

SHE:300452 Revenue

Anhui Sunhere Pharmaceutical Excipients had revenue of 246.78M CNY in the quarter ending September 30, 2026, with 9.36% growth. This brings the company's total for the last twelve months to 1.01B, up 8.56% year-over-year. In the year 2025, Anhui Sunhere Pharmaceutical Excipients had annual revenue of 942.80M with 6.82% growth. That makes Anhui Sunhere Pharmaceutical Excipients the 19,508th largest company in the world by revenue and 3,564th in China.

• Revenue (ttm): 1.01B
• Revenue Growth: +8.56%
• P/S Ratio: 2.64
• Revenue / Employee: 897.98K
• Employees: 1,130
• Market Cap: 2.68B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medicine Manufacturing 942.40M 100.0%
• Site Lease Income 395.94K 0.0%

By Geography

Chart

• East China 359.79M 38.2%
• Overseas 184.19M 19.5%
• North China, Northeast Region 136.17M 14.4%
• Southern China 99.03M 10.5%
• Central China 87.50M 9.3%
• Southwest and Northwest Region 76.12M 8.1%

Fiscal year ended Dec 31, 2025 See the full SHE:300452 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	942.80M	60.22M	6.82%
Dec 31, 2024	882.57M	43.31M	5.16%
Dec 31, 2023	839.26M	134.73M	19.12%
Jan 1, 2023	704.53M	87.82M	14.24%
Dec 31, 2021	616.71M	85.51M	16.10%

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error